IJNRD Research Journal

Click Here

WhatsApp editor@ijnrd.org
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 8

Issue Published : 88

Article Submitted : 26066

Article Published : 7438

Total Authors : 18836

Total Reviewer : 971

Total Countries : 150

Indexing Partner

Join RMS/Earn 300


This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: A Review on Post Approval Drug Safety Surveilliance
Authors Name: Prof. Shital G. Dhanmane , Ms.Pallavi. D.Hudekar , Ms.Mayuri.V.Chavan , Ms.Madhuri.D. Morey , Ms.NIkita .S. Lavhale
Download E-Certificate: Download
Author Reg. ID:
Published Paper Id: IJNRD2207072
Published In: Volume 7 Issue 7, July-2022
Abstract: A Review on Post Approval Drug Safety Surveilliance Dhanmane S. G*, Hudekar P. D, Chavan M.V, Morey M. D, Lavhale N.S. shital27489@gmail.com, pallavihudekar97@gmail.com, mayurichavan270@gmail.com moreymadhuri832@gmail.com, nikitalavhale1785@gmail.com Abstract Drug safety surveillance following the drug-approval process, concerns remain regarding the safety of new drugs that are introduced into the marketplace. In the case of rare adverse events, the number of subjects that are treated in randomized controlled trials is invariably inadequate to determine the safety of the new pharmaceutical. Identifying safety signals for new and/or existing drugs is a major priority in the protection of public health. Unfortunately, design, analysis, and available data are often quite limited for detecting in a timely fashion any potentially harmful effects of drugs. In this review, we examine a variety of approaches for determining the possibility of adverse drug reactions. Our review includes spontaneous reports, meta-analysis of randomized controlled clinical trials, ecological studies, and analysis of medical claims data. We consider both experimental design and analytic problems as well as potential solutions. Many of these methodologies are then illustrated. This guide proposes the development of a national post-marketing surveillance program that consists of a series of medicines quality sampling and testing activities each with an objective dictated by a country’s specific needs. Each sampling and testing activity is established with its own yearly plan developed in consultation with relevant stakeholders. Post-marketing surveillance and the associated sampling and testing activities should be coordinated and owned by the NRA and designed to address predefined objectives. The national post-marketing surveillance program should be reviewed, updated, and revised yearly.
Keywords: Key Words: Drug Safety, Adverse Drug Reaction, Post-Marketing Surveillance, Spontaneous Reporting.
Cite Article: "A Review on Post Approval Drug Safety Surveilliance", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 7, page no.582-606, July-2022, Available :http://www.ijnrd.org/papers/IJNRD2207072.pdf
Downloads: 000114662
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2207072
Registration ID: 181970
Published In: Volume 7 Issue 7, July-2022
DOI (Digital Object Identifier):
Page No: 582-606
Country: Buldana, Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2207072
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2207072
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)

Providing A digital object identifier by DOI
How to Get DOI? DOI


Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media


This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300